Report cover image

Global Antibiotic Resistance Market

Publisher Coherent Market Insights
Published Jul 15, 2025
Length 180 Pages
SKU # CMI20303023

Description

The global antibiotic resistance market has been witnessing significant growth in recent years. Antibiotics are medicines used to prevent and treat bacterial infections. They either kill bacteria or stop them from multiplying. Some of the most commonly used antibiotics include penicillin, amoxicillin, cephalosporins etc. However, over the past few decades, antibiotic resistance has been emerging as a major public health threat globally. When bacteria become antibiotic resistant, the medicines used to treat the infections they cause become ineffective. This leads to longer illness and increased death rates. The rising prevalence of bacterial strains that are resistant to various antibiotic classes is primarily attributable to misuse and overuse of antibiotics. Other factors that drive antibiotic resistance include the lack of development of new antibiotics, lack of sanitation and hygiene in many parts of the world, increased international travels, etc. If not addressed properly, antibiotic resistance could lead to serious health issues and affect patient outcomes.

Market Dynamics

The global antibiotic resistance market growth is driven by various factors such as increasing prevalence of antibiotic-resistant bacterial infections, lack of new antibiotic development, misuse and overuse of existing antibiotics, limited infection control in many developing regions, etc. However, the development of alternative treatment options and stringent regulations regarding antibiotic usage could restrain the market growth. The market provides opportunities for companies focusing on the development of novel antibiotics with new mechanisms of action. Key players are also exploring alternative therapeutic approaches like phage therapy, vaccines, monoclonal antibodies etc. to counter antibiotic resistance. Partnerships between industry and academia hold promise to address this looming healthcare crisis.

Key Features of the Study
  • This report provides an in-depth analysis of the global antibiotic resistance market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2025–2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global antibiotic resistance market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Melinta Therapeutics, Merck & Co., Inc., Allergan, Pfizer Inc., Tetraphase Pharmaceutical, Inc., Theravance Biopharma, WOCKHARDT, Entasis Threapeutics, Paratek Pharmaceutials, Inc., Seres Therapeutics, Achaogen Inc., Basilea Pharmaceutical Ltd., Nabriva Threapeutics plc, NEMESIS BIOSCIENCE LTD.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global antibiotic resistance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibiotic resistance market.
Market Segmentation
  • Global Antibiotic Resistance Market, By Drug Class
  • Oxazolidinones
  • Lipoglycopeptides
  • Tetracyclines
  • Cephalosporins
  • Others (Combination therapies, etc.)
  • Global Antibiotic Resistance Market, By Disease
  • cUTI (Complicated Urinary Tract Infections)
  • CDI (Clostridioides difficile Infection)
  • ABSSSI (Acute bacterial skin and skin structure infections)
  • HABP (Hospital-acquired bacterial pneumonia)
  • CABP (Community-acquired pneumonia)
  • cIAI (Complicated intra-abdominal infection)
  • Others (BSI (Bloodstream infection), etc.)
  • Global Antibiotic Resistance Market, By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Antibiotic Resistance Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Top Companies in the Global Antibiotic Resistance Market
  • Melinta Therapeutics
  • Merck & Co., Inc.
  • Allergan
  • Pfizer Inc.
  • Tetraphase Pharmaceutical, Inc.
  • Theravance Biopharma
  • WOCKHARDT
  • Entasis Threapeutics
  • Paratek Pharmaceutials, Inc.
  • Seres Therapeutics
  • Achaogen Inc.
  • Basilea Pharmaceutical Ltd.
  • Nabriva Threapeutics plc
  • NEMESIS BIOSCIENCE LTD.

Table of Contents

180 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Disease
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Rising prevalence of infectious diseases
Advancement in antibiotic resistance diagnosis
Growing number of R&D activities
Key Highlights
Guidelines for the Temporary Staffing Agency & the Host Employer
Market Trends
PEST Analysis
Investments and Fundings
Mergers, Acquisitions, and Collaborations
Key Services Offered
Identification of Top Market Players
Nurse Staffing Dominance
Healthcare Spending by Country
4. Global Antibiotic Resistance Market, By Drug Class, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Oxazolidinones
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Lipoglycopeptides
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Tetracyclines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cephalosporins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Combination therapies, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Antibiotic Resistance Market, By Disease, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
cUTI (Complicated Urinary Tract Infections)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CDI (Clostridioides difficile Infection)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
ABSSSI (Acute bacterial skin and skin structure infections)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HABP (Hospital-acquired bacterial pneumonia)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CABP (Community-acquired pneumonia)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
cIAI (Complicated intra-abdominal infection)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (BSI (Bloodstream infection), etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Antibiotic Resistance Market, By Distribution Channel, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Antibiotic Resistance Market, By Region, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2021 – 2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (USD Bn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profile
Melinta Therapeutics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Allergan
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Tetraphase Pharmaceutical, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
TeamHealth
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Theravance Biopharma
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
WOCKHARDT
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Entasis Threapeutics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Paratek Pharmaceutials, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Seres Therapeutics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Achaogen Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Basilea Pharmaceutical Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Nabriva Threapeutics plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
NEMESIS BIOSCIENCE LTD.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
9. Section
References
Research Methodology
About us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us